NEURON BIO D2015-MARZO

Trading sesion


02/04/2015 Close

0.2000

Last price


1.39 mill. €

Capitalisation

-9.50

Dif.(%)


37.93

% Year 2015

Excluded 07/04/2015

Last Trade

Last

0.2000

Ref.

0.2210

Dif.(%)

-9.50

Volume (Shares)

971,938

Turnover (€x1000)

208.85

Security

Security name

NEURON BIO D2015-MARZO

Ticker

NEU.D

ISIN

ES0666198918

NIF

A-18758300

Capital Admitted

-

Shares Admitted

6.937.500

Nominal

-

Trading

Continuo

Liquidity Provider

GVC Gaesco Beka, S.V., S.A.

Registered Advisor

GVC Gaesco Beka, S.V., S.A.

Auditor

DELOITTE, S.L

Address

CL/ AVICENA 4, 18016 GRANADA

Contact

accionistas@neuronbio.com

Historical Summary

 2015 until 2/04

Capital Admitted (thousands of euros)

n/a

Shares (x 1,000)

6,938

Period Close Price (euros)

0.2000

Period Last Price (euros)

0.2000

Period High Price (euros)

0.3640

Period Low Price (euros)

0.0930

Capitalisation (thousands of euros)

1,388

Volume (thousands of shares)

5,545

Turnover (thousands of euros)

1,325

Company Profile

Neuron Bio (ticker: NEU) is the parent company of a group of R&D companies that develop research in two areas of biotechnology: the Biosanitary sector (Neuron Biolabs) and the Bioindustrial sector (Neol Bio).

Neuron Bio is listed in the Alternative Stock Market (ASM) in Spain.   

Neuron Biolabs develops biosolutions for application in the pharmaceutical and agri-food industries through its specialised divisions. The Pharma division is dedicated fundamentally to the search for preventative drugs and treatments for neurodegenerative diseases, particularly Alzheimer’s disease. The Diagnostic division develops tools and biomarkers for the diagnosis of diseases of the Central Nervous System, as in the case of Alzheimer’s. The Services Division offers a wide range of R&D services in the fields of biomedicine, toxicology and agri-food.   

Neol Bio (ticker: NEOL) is dedicated to the development of innovative biotechnological, industrial microbial processes for application in different sectors: functional food, oleochemistry, bioenergy and other bioproducts. These processes have been developed for clients and as internal R&D projects. Amongst the technologies that Neol Bio has developed is an exclusive platform for the production of high-value oils which has culminated in the creation of Neol Nutritional Products, a company dedicated to the production and commercialisation of high-quality Omega-3 DHA Oil with microalgae selected by Neol Bio

Relevant Facts and Notices

Significant participations

Financial Reports

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.

MARKET STATUS

If an issue occurs, the message "TRADING" will change to "MARKET ISSUE" to reflect that a market event has occurred. By clicking on the Issue of the published alert it will be possible to access the information and intraday updates associated with this incident, which will be published immediately.

Note: BME will use its discretion to assign the severity of an incident